Deutsche Bank’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Sell |
325,288
-9,234
| -3% | -$60K | ﹤0.01% | 1662 |
|
|
2025
Q1 | $2.65M | Sell |
334,522
-24,398
| -7% | -$193K | ﹤0.01% | 1556 |
|
|
2024
Q4 | $4.55M | Buy |
358,920
+35,460
| +11% | +$449K | ﹤0.01% | 1365 |
|
|
2024
Q3 | $4.51M | Buy |
323,460
+121,593
| +60% | +$1.69M | ﹤0.01% | 1298 |
|
|
2024
Q2 | $2.78M | Buy |
201,867
+23,693
| +13% | +$326K | ﹤0.01% | 1466 |
|
|
2024
Q1 | $2.94M | Buy |
178,174
+1,018
| +0.6% | +$16.8K | ﹤0.01% | 1464 |
|
|
2023
Q4 | $2.59M | Buy |
177,156
+19
| +0% | +$277 | ﹤0.01% | 1530 |
|
|
2023
Q3 | $2.17M | Buy |
177,137
+9,219
| +5% | +$113K | ﹤0.01% | 1309 |
|
|
2023
Q2 | $2M | Sell |
167,918
-417
| -0.2% | -$4.98K | ﹤0.01% | 1621 |
|
|
2023
Q1 | $2.25M | Buy |
168,335
+151,525
| +901% | +$2.03M | ﹤0.01% | 1624 |
|
|
2022
Q4 | $362K | Buy |
16,810
+5,212
| +45% | +$112K | ﹤0.01% | 2618 |
|
|
2022
Q3 | $232K | Buy |
11,598
+554
| +5% | +$11.1K | ﹤0.01% | 2845 |
|
|
2022
Q2 | $198K | Sell |
11,044
-2,219
| -17% | -$39.8K | ﹤0.01% | 3159 |
|
|
2022
Q1 | $132K | Buy |
13,263
+6,561
| +98% | +$65.3K | ﹤0.01% | 3441 |
|
|
2021
Q4 | $113K | Buy |
6,702
+363
| +6% | +$6.12K | ﹤0.01% | 3597 |
|
|
2021
Q3 | $150K | Buy |
+6,339
| New | +$150K | ﹤0.01% | 3662 |
|